150 participants
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2025-10-27
- Completion:
- 2030-09-22
Conditions
- PARKINSON DISEASE (Disorder)
Interventions
- DRUG
No Results Yet